# Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus

> **NCT07645001** · NA · RECRUITING · sponsor: **Riphah International University** · enrollment: 200 (estimated)

## Conditions studied

- Gestational Diabetes

## Interventions

- **OTHER:** GRP 1 Tab metformin
- **OTHER:** GRP 2 Inj insulin
- **OTHER:** GRP 3 Tab metformin + HI flora sachet
- **OTHER:** GRP 4 Inj insulin + HI flora sachet

## Key facts

- **NCT ID:** NCT07645001
- **Lead sponsor:** Riphah International University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-29
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645001, "Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*